Inhibitor Therapeutics Inc Sustainability Reports
Inhibitor Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It focuses on developing and commercializing therapeutics for patients with specific cancers and non-cancerous proliferation disorders.
Sector: Manufacturing
Country: United States
Exchange: OTC Markets
LEI: 549300X9PVE6FC13Q538
FIGI: BBG001SBC1N1
2 reports from 2020 to 2024
